Population
Children and adults with primary pulmonary hypertension
Design
Review
Authors
Loading...
Supports potential survival benefit with continuous prostacyclin; leaves open need for randomized trials in children and adults.
Survival in primary pulmonary hypertension, historically a rapidly fatal disease, has improved with the advent of sustained intravenous prostacyclin treatment and chronic anticoagulation.
Sheila G. Haworth (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: